Iitri -DOG MTD-DRF studies-to 4
Ended Awarded Last action
- Contract number
- 75N95024F00003
- Awardee
-
IIT Research Institute UEI DGBUFQYMKWB5 Part of Illinois Institute Of Technology
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $224,716
Award facts
- Contract value 100% obligated
- $224,716.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Chicago, IL 60616, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $13,679 | |
| Original award | $211,037 |
About this award
This is a federal contract award issued by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a non-profit division of the Illinois Institute of Technology. The $224,716.00 contract is a delivery order under a larger indefinite delivery/indefinite quantity (IDIQ) vehicle called the Pharmacology and Toxicology for Therapeutics Program, which has a total ceiling value of $174.5 million. Under this delivery order, IITRI will conduct Department of Defense (DOD)-mandated Dose Range-Finding (DRF) studies. The contract does not have a set-aside designation. IITRI has extensive experience supporting the preclinical development of various therapeutic candidates, including for neurological disorders, through contracts and grants from federal agencies like NINDS, the National Cancer Institute, and the National Center for Advancing Translational Sciences.
Quick answers
Who was awarded contract 75N95024F00003?
75N95024F00003 was awarded to IIT Research Institute by National Institute on Drug Abuse (National Institutes of Health) on March 15, 2024.
How much is contract 75N95024F00003 worth?
The government has obligated $224,716 on 75N95024F00003.
Which agency awarded contract 75N95024F00003?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95024F00003, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Is contract 75N95024F00003 an order under another contract?
Yes. 75N95024F00003 is a delivery order under 75N95021D00026, an indefinite delivery contract.
Was contract 75N95024F00003 competed?
The extent of competition for 75N95024F00003 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award